Understanding how certain genes help bone cells develop in the face
Enhancer activation mechanisms in cranial neural crest osteoblast differentiation
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10878771
This study is looking at how certain DNA sequences help turn specific cells into bone-forming cells, which could help us understand the genetic causes of facial bone disorders and find new ways to treat them.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10878771 on ClinicalTrials.gov |
What this research studies
This research investigates the role of enhancers, which are DNA sequences that help activate genes, in the differentiation of cranial neural crest cells into osteoblasts, the cells responsible for bone formation. By studying how chromatin, the material that makes up chromosomes, changes during this process, researchers aim to understand the genetic factors that contribute to craniofacial disorders. The study uses advanced techniques to analyze these changes in mouse models that mimic human conditions, focusing on the molecular disruptions caused by mutations in chromatin-modifying enzymes. This work could provide insights into the underlying mechanisms of craniofacial abnormalities and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with craniofacial disorders or those with a family history of such conditions.
Not a fit: Patients without craniofacial disorders or those whose conditions are unrelated to chromatin modifications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating craniofacial disorders by targeting the genetic mechanisms involved in bone cell development.
How similar studies have performed: Previous research has shown success in understanding gene regulation through enhancer mechanisms, suggesting that this approach may yield valuable insights.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHPARGEL, KARL BRYAN — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: SHPARGEL, KARL BRYAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.